Obesity is associated with systemic low-grade inflammation [42], contributing to the development of insulin resistance, a key feature of T2DM, by disrupting insulin signaling and glucose metabolism [21,22]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.